Oncology Meeting: EORTC – IBCD 2020 (23 October 2020)
IBCD 2020 will explore routes through the constantly evolving scientific, methodological and regulatory environment for drug and biomarker development. The EORTC, NCI, EMA, and AACR with the involvement of FDA and PMDA specialists endeavour to build upon the...
read moreNEW EU STRATEGY: Pharmaceutical Strategy – Timely patient access to affordable medicines
The EU is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry. It will address: the life cycle of medicines from R&D to authorisation and patient access...
read more
ESMO provides first recommendations on use of next-generation sequencing in metastatic cancer
Cancerworld has published an article, "ESMO provides first recommendations on use of next generation sequencing in metastatic cancer." To read the full article and Prof. Ruth Plummer's comment on the ESMO publication, click the following link:...
read moreCDDF announces new leadership – 22 June 2020
CDDF is excited to announce newly elected board members and officers appointed at its first General Assembly since its establishment as a non-profit association in Belgium that took place on 9 June 2020. The CDDF wishes to thank its outgoing board members, Prof. Leif...
read moreCDDF & EORTC announces new collaboration
European Organisation for Research and Treatment of Cancer (EORTC) and Cancer Drug Development Forum (CDDF) announce their new collaboration on series of clinical cancer research related workshops covering all aspect from early dug...
read more
NEW CDDF brochure
CDDF has been published its NEW CDDF brochure. Click the link to read the latest version.
read more